Celadon Pharmaceuticals PLC (CEL)

London
112.75
+5.25(+4.88%)
  • Volume:
    4,930
  • Bid/Ask:
    100.00/115.00
  • Day's Range:
    112.75 - 112.75

CEL Overview

Prev. Close
107.5
Day's Range
112.75-112.75
Revenue
-
Open
107.5
52 wk Range
47.5-175
EPS
-0.072
Volume
4,930
Market Cap
66.3M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
141,708
P/E Ratio
-20.48
Beta
1.04
1-Year Change
-31.96%
Shares Outstanding
61,669,773
Next Earnings Date
-
What is your sentiment on Celadon Pharmaceuticals?
or
Vote to see community's results!

Celadon Pharmaceuticals PLC Company Profile

Celadon Pharmaceuticals PLC Company Profile

Employees
4

Celadon Pharmaceuticals Plc is a United Kingdom-based pharmaceutical company. The Company is engaged in research, cultivation, manufacturing and supply of cannabinoid-based medicines. The Company is focused on growing indoor hydroponic cannabis initially for the chronic pain market. It is also focused on improving the quality of life for chronic pain sufferers, as well as exploring the potential of cannabinoid-based medicines for other conditions, such as autism and multiple sclerosis. The Company's facility comprises an indoor, closed-loop hydroponic system to ensure cannabis plants are cultivated under a highly specific climate, light and with irrigation control. The Company's subsidiary, LVL Health is a medical cannabis clinic for chronic pain that owns a medicines and healthcare products regulatory agency (MHRA) conditionally approved cannabis trial using cannabis-based medicinal products to treat chronic pain in the United Kingdom.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong SellStrong SellBuyBuy
Technical IndicatorsStrong BuyStrong SellStrong SellNeutralNeutral
SummaryStrong BuyStrong SellStrong SellNeutralNeutral